Håvard Klemsdal
Direttore/Membro del Consiglio presso Xellia Pharmaceuticals AS
Provenienza dei contatti di primo grado di Håvard Klemsdal
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Xellia Pharmaceuticals AS
 Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Håvard Klemsdal tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Medical/Nursing Services | Chief Executive Officer Director/Board Member Chief Executive Officer | |
| Heriot-Watt University | College/University | Masters Business Admin | |
| BI Norwegian Business School | College/University | Undergraduate Degree | |
Vectron Biosolutions AS
 Vectron Biosolutions AS BiotechnologyHealth Technology Vectron Biosolutions AS is a Norwegian company that specializes in developing protein production processes for researchers and manufacturers. The company is based in Trondheim, NO. The company's mission is to support their customers in realizing higher success rates, greater yields, and reduced cost of goods. The company offers tailor-made solutions by leveraging their proprietary expression technologies and extensive experience. and has subsidiaries in the United States. The company was founded in 2008, and Trond Erik Vee Aune has been the CEO of the company since 2008. | Biotechnology | Chairman | |
Zerion Pharma ApS
 Zerion Pharma ApS Pharmaceuticals: MajorHealth Technology Zerion ApS operates as pharmaceutical development company. It also develops and improve drug products. The company was founded on January 14, 2019 and is headquartered in Birkerod, Denmark. | Pharmaceuticals: Major | Chairman | |
Sandoz GmbH
 Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Technology Sydney | College/University | Masters Business Admin | |
| University of Copenhagen | College/University | Graduate Degree | |
| NC Advisory A/S | Investment Managers | Private Equity Analyst | |
| NAVAMEDIC ASA | Medical Distributors | Director/Board Member |
Statistiche
Distribuzione geografica
| Danimarca | 5 |
| Norvegia | 4 |
| Regno Unito | 2 |
| Stati Uniti | 2 |
| Austria | 2 |
Settori
| Health Technology | 5 |
| Consumer Services | 5 |
| Health Services | 2 |
| Finance | 2 |
| Distribution Services | 2 |
Posizioni
| Director/Board Member | 7 |
| Chief Executive Officer | 5 |
| Chairman | 3 |
| Masters Business Admin | 2 |
| President | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Håvard Klemsdal
- Connessioni Società
